Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Amin E Nawar. (2022) Modified Microneedle for Suprachoroidal Injection of Triamcinolone Acetonide Combined with Intravitreal Injection of Ranibizumab in Branch Retinal Vein Occlusion Patients. Clinical Ophthalmology 16, pages 1139-1151.
Read now
Read now
Christopher M. Maatouk, Resya Sastry & Rishi P. Singh. (2022) Long term outcomes following anti-VEGF therapy for diabetic macular edema. Expert Review of Ophthalmology 17:5, pages 307-319.
Read now
Read now
Wenbin Wei, Youxin Chen, Bojie Hu, Mingwei Zhao, Mei Han, Hong Dai, Harvey S Uy, Michelle Y Chen, Kate Wang, Jenny Jiao, Jean Lou & Xiao-Yan Li. (2021) Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region. Clinical Ophthalmology 15, pages 4097-4108.
Read now
Read now
Alfredo Adán, Francisco Cabrera, Marta S Figueroa, Enrique Cervera, Francisco J Ascaso, Patricia Udaondo, Maximino Abraldes, Miguel Ángel Reyes, Marta Pazos, Bernardete Pessoa & Félix Armadá. (2020) Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations. Clinical Ophthalmology 14, pages 2091-2107.
Read now
Read now
Angela S. Li, Malini Veerappan, Vaishali Mittal & Diana V. Do. (2020) Anti-VEGF agents in the management of diabetic macular edema. Expert Review of Ophthalmology 15:5, pages 285-296.
Read now
Read now
Articles from other publishers (14)
Einar Stefansson, Thorstein Loftsson, Michael Larsen, András Papp, Kai Kaarniranta, Marion R. Munk, Pravin Dugel & Ramin Tadayoni. (2022) Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double‐masked, vehicle‐controlled study. Acta Ophthalmologica 101:1, pages 22-33.
Crossref
Crossref
Silvia NW Hertzberg, Morten Carstens Moe, Øystein Kalsnes Jørstad, Beáta Éva Petrovski, Emily Burger & Goran Petrovski. (2022) Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema. Acta Ophthalmologica 100:8.
Crossref
Crossref
Amin E Nawar. (2022) Effectiveness of Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema Using a Modified Microneedle. Clinical Ophthalmology Volume 16, pages 3821-3831.
Crossref
Crossref
Noura Al Qassimi, Igor Kozak, Maysoon Al Karam, Piergiorgio Neri, Patricio M. Aduriz-Lorenzo, Alaa Attawan, Mohamed Awadalla, Ahmed El Khashab, Mohamed Abdul-Nabi, Ammar Safar, Hanan Al Shamsi, Prasan Rao, Madhav Rao, Amr Farid & Avinash Gurbaxani. (2022) Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology. Ophthalmology and Therapy 11:5, pages 1937-1950.
Crossref
Crossref
Marion R. Munk, Gabor Mark Somfai, Marc D. de Smet, Guy Donati, Marcel N. Menke, Justus G. Garweg & Lala Ceklic. (2022) The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers. International Journal of Molecular Sciences 23:14, pages 7585.
Crossref
Crossref
Michael A. Singer, Veeral Sheth, Sam E. Mansour, Brandon Coughlin & Victor H. Gonzalez. (2022) Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema. Ophthalmology 129:6, pages 605-613.
Crossref
Crossref
Bing Liu, Guangfeng Ma, Jing Hou & Chenyang Cong. (2022) Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema. Journal of Ophthalmology 2022, pages 1-6.
Crossref
Crossref
Almila Sarigul SezenozImren Akkoyun, Fatma HelvaciogluNihan HaberalAttila DagdevirenDidem BacanliGursel YilmazSibel Oto. (2021)
Antiproliferative and Mitochondrial Protective Effects of Apigenin in an Oxygen-Induced Retinopathy
In Vivo
Mouse Model
. Journal of Ocular Pharmacology and Therapeutics 37:10, pages 580-590.
Crossref
Crossref
Omer Karti & Ali Osman Saatci. (2021) Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema. World Journal of Diabetes 12:8, pages 1220-1232.
Crossref
Crossref
David S. Boyer, Joerg F. Rippmann, Michael S. Ehrlich, Remko A. Bakker, Victor Chong & Quan Dong Nguyen. (2021) Amine oxidase copper-containing 3 (AOC3) inhibition: a potential novel target for the management of diabetic retinopathy. International Journal of Retina and Vitreous 7:1.
Crossref
Crossref
Lusha Cen, Fengling Xing, Liying Xu & Yi Cao. (2020) Potential Role of Gene Regulator NFAT5 in the Pathogenesis of Diabetes Mellitus. Journal of Diabetes Research 2020, pages 1-13.
Crossref
Crossref
Jay Chhablani, Kelvin Wong, Gavin S. Tan, Aditya Sudhalkar, Augustinus Laude, Chui Ming Gemmy Cheung, Paul Zhao, Harvey Uy, Jeffrey Lim, Sherman Valero, Nor Fariza Ngah & Adrian Koh. (2020) Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus Guidelines. Asia-Pacific Journal of Ophthalmology 9:5, pages 426-434.
Crossref
Crossref
Sadie K. Dierschke, Allyson L. Toro, William P. Miller, Siddharth Sunilkumar & Michael D. Dennis. (2020) Diabetes enhances translation of Cd40 mRNA in murine retinal Müller glia via a 4E-BP1/2–dependent mechanism. Journal of Biological Chemistry 295:31, pages 10831-10841.
Crossref
Crossref
Mojca Urbančič, Pia Klobučar, Matej Zupan, Katja Urbančič & Alenka Lavrič. (2020) Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice. Journal of Ophthalmology 2020, pages 1-8.
Crossref
Crossref